Osteoimmunologie – revisited

• Literatur

• 1 Baschant U, Frappart L, Rauchhaus U. et al. Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc Natl Acad Sci U S A. 2011
• 2 Thiele S, Ziegler N, Tsourdi E. et al. Selective glucocorticoid receptor modulation maintains bone mineral density in mice. J Bone Miner Res 2012; 27 (11) 2242-2245.
• 3 Rauner M, Thiele S, Sinningen K. et al. Effects of the selective glucocorticoid receptor modulator compound A on bone metabolism and inflammation in male mice with collagen-induced arthritis. Endocrinology 2013; 154 (10) 3719-3728.
• 4 Bozec A, Zaiss MM, Kagwiria R. et al. T Cell Costimulation Molecules CD80/86 Inhibit Osteoclast Differentiation by Inducing the IDO/Tryptophan Pathway. Sci Transl Med. 2014 06. (235): 235ra60.
• 5 Harre U, Georgess D, Bang H. et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012; 122 (05) 1791-1802.
• 6 Seeling M, Hillenhoff U, David JP. et al. Inflammatory monocytes and Fcγ receptor IV on osteoclasts are critical for bone destruction during inflammatory arthritis in mice. Proc Natl Acad Sci U S A. 2013 Jun 10.
• 7 Uderhardt S, Herrmann M, Oskolkova OV. et al. 12/15-Lipoxygenase Orchestrates the Clearance of Apoptotic Cells and Maintains Immunologic Tolerance. Immunity. 2012 Apr 11.
• 8 Rauner M, Sipos W, Thiele S, Pietschmann P. Advances in osteoimmunology: pathophysiologic concepts and treatment opportunities. Int Arch Allergy Immunol 2013; 160 (02) 114-125.
• 9 Scholtysek C, Fu H, Katzenbeisser J. et al. PPARβ governs Wnt-signaling and bone turnover. Nat Med. 2013 Mar 31.
• 10 Kiechl S, Wittmann J, Giaccari A. et al. Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med. 2013 Feb 10.